Pulmonx Corporation (LUNG)
Pulmonx Statistics
Share Statistics
Pulmonx has 40.25M shares outstanding. The number of shares has increased by 2.53% in one year.
| Shares Outstanding | 40.25M |
| Shares Change (YoY) | 2.53% |
| Shares Change (QoQ) | 0.78% |
| Owned by Institutions (%) | 91.33% |
| Shares Floating | 34.62M |
| Failed to Deliver (FTD) Shares | 597 |
| FTD / Avg. Volume | 0.17% |
Short Selling Information
The latest short interest is 1.23M, so 3.1% of the outstanding shares have been sold short.
| Short Interest | 1.23M |
| Short % of Shares Out | 3.1% |
| Short % of Float | 4.38% |
| Short Ratio (days to cover) | 4.68 |
Valuation Ratios
The PE ratio is -4.71 and the forward PE ratio is -3.54. Pulmonx's PEG ratio is 0.47.
| PE Ratio | -4.71 |
| Forward PE | -3.54 |
| PS Ratio | 3.17 |
| Forward PS | 0.6 |
| PB Ratio | 3.09 |
| P/FCF Ratio | -8.05 |
| PEG Ratio | 0.47 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Pulmonx.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.58, with a Debt / Equity ratio of 0.66.
| Current Ratio | 5.58 |
| Quick Ratio | 4.88 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | -0.98 |
| Debt / FCF | -1.71 |
| Interest Coverage | -16.45 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $287.93K |
| Profits Per Employee | $-193.79K |
| Employee Count | 291 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.29 |
Taxes
| Income Tax | 500K |
| Effective Tax Rate | -0.89% |
Stock Price Statistics
The stock price has increased by -29.04% in the last 52 weeks. The beta is 0.61, so Pulmonx's price volatility has been higher than the market average.
| Beta | 0.61 |
| 52-Week Price Change | -29.04% |
| 50-Day Moving Average | 6.96 |
| 200-Day Moving Average | 6.86 |
| Relative Strength Index (RSI) | 37.2 |
| Average Volume (20 Days) | 357.13K |
Income Statement
In the last 12 months, Pulmonx had revenue of 83.79M and earned -56.39M in profits. Earnings per share was -1.44.
| Revenue | 83.79M |
| Gross Profit | 62M |
| Operating Income | -57.7M |
| Net Income | -56.39M |
| EBITDA | -57.7M |
| EBIT | -59.4M |
| Earnings Per Share (EPS) | -1.44 |
Balance Sheet
The company has 70.91M in cash and 56.47M in debt, giving a net cash position of 14.43M.
| Cash & Cash Equivalents | 70.91M |
| Total Debt | 56.47M |
| Net Cash | 14.43M |
| Retained Earnings | -467.56M |
| Total Assets | 162.85M |
| Working Capital | 111.81M |
Cash Flow
In the last 12 months, operating cash flow was -31.54M and capital expenditures -1.45M, giving a free cash flow of -32.98M.
| Operating Cash Flow | -31.54M |
| Capital Expenditures | -1.45M |
| Free Cash Flow | -32.98M |
| FCF Per Share | -0.84 |
Margins
Gross margin is 74%, with operating and profit margins of -68.87% and -67.3%.
| Gross Margin | 74% |
| Operating Margin | -68.87% |
| Pretax Margin | -66.71% |
| Profit Margin | -67.3% |
| EBITDA Margin | -68.87% |
| EBIT Margin | -68.87% |
| FCF Margin | -39.37% |
Dividends & Yields
LUNG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for LUNG is $12, which is 131.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $12 |
| Price Target Difference | 131.7% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Scores
| Altman Z-Score | -2.39 |
| Piotroski F-Score | 4 |